Skip to main content
SpringerLink
Log in

Efficacy of NSAIDs in the Treatment of Rheumatic Diseases

  • Chapter
  • First Online:
NSAIDs and Aspirin

Abstract

Nonsteroidal anti-inflammatory drugs are a chemically diverse group of compounds that share three cardinal characteristics; they are anti-inflammatory, analgesic, and antipyretic. They are approved by regulatory authorities worldwide for the treatment of patients with osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and some forms of juvenile idiopathic arthritis. They are also used for the treatment of acute gout, acute pain, dysmenorrhea, and chronic low back pain. This chapter will review the data on the efficacy of this class of agents in the treatment of osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and acute gout.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 69.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 89.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Day RO, Graham GG. Non-steroidal antiinflammatory drugs (NSAIDs). BMJ. 2013;346:f3195.

    PubMed  Google Scholar 

  2. Patrono C. Non-steroidal anti-inflammatory drugs. Chapter 53 in Hochberg MC, Silman AJ, Smolen JS, Weinblatt ME, Weisman MH, editors. Rheumatology. 6th ed. Philadelphia: Mosby/Elsevier; 2015. p. 415–22.

    Google Scholar 

  3. Castellsague J, Riera-Guardia N, Calingaert B, Varas-Lorenzo C, Fourrier-reglat A, Nicotra F, et al. Individual NSAIDs and upper gastrointestinal complications: a systematic review and meta-analysis of observational studies (the SOS project). Drug Saf. 2012;35:1127–46.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Coxib and traditional NSAID Trialists’ (CNT) Collaboration. Vascular and upper gastrointestinal effects of nonsteroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomized trials. Lancet. 2013;382:769–79.

    Article  Google Scholar 

  5. Baum C, Kennedy DL, Forbes MB. Utilization of nonsteroidal anti-inflammatory drugs. Arthritis Rheum. 1985;28:686–91.

    Article  CAS  PubMed  Google Scholar 

  6. Aitken M, Kleinrock M, Lyle J, Caskey L. Medicine use and shifting costs of healthcare: a review of the use of medicines in the United States in 2013. Parsinnapany, NJ: IMS Institute for Healthcare Informatics; 2014.

    Google Scholar 

  7. Simon LS, Hochberg MC. Nonsteroidal anti-inflammatory drugs. In: Biljsma JWJ, Doherty M, Lohmander S, editors: Oxford textbook of osteoarthritis and crystal arthropathy. 3rd ed. Oxford: Oxford University Press; 2016, in press.

    Google Scholar 

  8. Jordan KM, Arden NK, Doherty M, Bannwarth B, Bijlsma JW, Dieppe P, et al. EULAR recommendations 2003: an evidence based approach to the management of knee osteoarthritis. Ann Rheum Dis. 2003;62:1145–55.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Zhang W, Doherty M, Arden N, Bannwarth B, Bijlsma J, Gunther KP, et al. EULAR evidence based recommendations for the management of hip osteoarthritis. Ann Rheum Dis. 2005;64:669–81.

    Article  CAS  PubMed  Google Scholar 

  10. Hochberg MC, Altman RD, April KT, Benkhalti M, Guyatt G, McGowan J, et al. American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee. Arthritis Care Res (Hoboken). 2012;64:465–74.

    Article  CAS  Google Scholar 

  11. McAlindon TE, Bannuru RR, Sullivan MC, Arden NK, Berenbaum F, Bierma-Zeinstra SM, et al. OARSI guidelines for the non-surgical management of knee osteoarthritis. Osteoarthritis Cart. 2014;22:363–88.

    Article  CAS  Google Scholar 

  12. National Clinical Guideline Centre (UK). Osteoarthritis: care and management in adults. London: National Institute for Health and Care Excellence. 2014 Feb.

    Google Scholar 

  13. Bruyere O, Cooper C, Pelletier JP, Branco J, Luisa Brandi M, Guillemin F, et al. An algorithm recommendation for the management of knee osteoarthritis in Europe and internationally: a report from a task force of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). Semin Arthritis Rheum. 2014;44(3):253–63.

    Article  PubMed  Google Scholar 

  14. Myeers J, Wielage RC, Han B, Price K, Gahn J, Paget M-A, et al. The efficacy of duloxetine, non-steroidal anti-inflammatory drugs, and opioids in osteoarthritis: a systematic literature review and meta-analysis. BMC Musculoskelet Disord. 2014;15:76.

    Article  Google Scholar 

  15. Kongtharvonskul J, Anothaisintawee T, McEvoy M, Attia J, Woratanarat P, Thankkinstrian A. Efficacy and safety of glucosamine, diacerein, and NSAIDs in osteoarthritis knee: a systematic review and network meta-analysis. Eur J Med Res. 2015;20:24.

    Article  PubMed  PubMed Central  Google Scholar 

  16. van Walsen A, Pandhi S, Nixon RM, Guyot P, Karabis A, Moore RA. Relative benefit-risk comparing diclofenac to other traditional non-steroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors in patients with osteoarthritis or rheumatoid arthritis: a network meta-analysis. Arth Res Ther. 2015;17:66.

    Article  Google Scholar 

  17. Bannuru RR, Schmid CH, Kent DM, Vaysbrot EE, Wong JB, McAlindon TE. Comparative effectiveness of pharmacologic interventions for knee osteoarthritis: a systematic review and network meta-analysis. Ann Intern Med. 2015;162:46–54.

    Article  PubMed  Google Scholar 

  18. Burmester G, Lanas A, Biasucci L, Hermann M, Lohmander S, Olivieri I, et al. The appropriate use of non-steroidal anti-inflammatory drugs in rheumatic disease: opinions of a multidisciplinary European expert panel. Ann Rheum Dis. 2011;70(5):818–22.

    Article  CAS  PubMed  Google Scholar 

  19. Scarpignato C, Lanas A, Blandizzi C, Lems WF, Hermann M, Hunt RH, for the International NSAID Consensus Group. Safe prescribing of non-steroidal anti-inflammatory drugs in patients with osteoarthritis: an expert consensus addressing benefits as well as gastrointestinal and cardiovascular risks. BMC Med. 2015;13:55.

    Google Scholar 

  20. Kvien TK. Nonsteroidal anti-inflammatory drugs and coxibs. In: Hochberg MC, Silman AJ, Smolen JS, Weinblatt ME, Weisman MH, editors. Rheumatoid arthritis. Philadelphia: Mosby/Elsevier; 2009. p. 295–9.

    Google Scholar 

  21. Gotzsche PC. Non-steroidal anti-inflammatory drugs. BMJ. 2000;320(7241):1058–61.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Garner S, Pidan D, Frankish R, et al. Celecoxib for rheumatoid arthritis. Cochrane Database Syst Rev. 2002;4, CD003831.

    PubMed  Google Scholar 

  23. Garner S, Pidan D, Frankish R, et al. Rofecoxib for rheumatoid arthritis. Cochrane Database Syst Rev. 2005;1, CD003685.

    PubMed  Google Scholar 

  24. Simon LS, Weaver AL, Graham DY, Kivitz AJ, Lipsky PE, Hubbard RC, Isakson PC, Verburg KM, Shawn SY, Zhao WW, Geis GS. The antiinflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: a randomized, controlled trial. JAMA. 1999;282:1921–8.

    Article  CAS  PubMed  Google Scholar 

  25. Chen Y-F, Jobanputra P, Barton P, Bryan S, Fry-Smith A, Harris G, et al: Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation. Health Technol Assess 2008;12(11):1–278.

    Google Scholar 

  26. Gotzsche PC. NSAIDs. BMJ Clin Evid. 2010 Jun 28; pii 1108.

    Google Scholar 

  27. Wienecke T, Gotzsche PC. Paracetamol versus nonsteroidal anti-inflammatory drugs for rheumatoid arthritis. Cochrane Database Syst Rev. 2004;1, CD003789.

    PubMed  Google Scholar 

  28. Crofford L. Use of NSAIDs in treating patients with arthritis. Arthritis Res Ther. 2013;15 Suppl 3:S2 [Epub 2013 Jul 24].

    PubMed  PubMed Central  Google Scholar 

  29. Kroon FPB, van der Burg LRA, Ramiro S, Landewe RBM, Buchbinder R, Falzon L, van der Heijde D. Non-steroidal anti-inflammatory drugs (NSAIDs) for axial spondyloarthritis (ankylosing spondylitis and non-radiographic axial spondyloarthritis). Cochrane Database Syst Rev. 2015;7, CD010952.

    PubMed  Google Scholar 

  30. Poddubnyy D, van der Heijde D. Therapeutic controversies in spondyloarthritis: nonsteroidal anti-inflammatory drugs. Rheum Dis Clin North Am. 2012;38(3):601–11.

    Article  PubMed  Google Scholar 

  31. Poddubnyy D, Rudwaleit M, Haibel H, Listing J, Marker-Hermann E, Zeidler H, Bruan J, Sieper J. Effect of non-steroidal anti-inflammatory drugs on radiographic spinal progression in patients with axial spondyloarthritis: results from the German Spondyloarthritis Inception Cohort. Ann Rheum Dis. 2012;71(10):1616–22.

    Article  CAS  PubMed  Google Scholar 

  32. Sieper J, Listing J, Poddubnyy D, Song IH, Hermann KG, Callhoff J, Syrbe U, Braun J, Rudwaleit M. Effect of continuous versus on-demand treatment of ankylosing spondylitis with diclofenac over 2 years on radiographic progression of the spine: results from a randomised multicenter trial (ENRADAS). Ann Rheum Dis. 2016;75(8):1438–43.

    Google Scholar 

  33. Khanna PP, FitzGerald J. Evolution of management of gout: a comparison of recent guidelines. Curr Opin Rheumatol. 2015;27:139–46.

    Article  PubMed  Google Scholar 

  34. Khanna D, Khanna PP, FitzGerald JD, Singh MK, Bae S, Neogi T, et al. 2012 American College of Rheumatology guidelines for management of gout. Part II: therapy and anti-inflammatory prophylaxis of acute gouty arthritis. Arthritis Care Res. 2012;64:1447–61.

    Article  CAS  Google Scholar 

  35. Jordan KM, Cameron JS, Snaith M, et al. British Society for Rheumatology and British Health professionals in Rheumatology guideline for the management of gout. Rheumatology (Oxford). 2007;46:1372–4.

    Article  Google Scholar 

  36. Sivera F, Andres M, Carmona L, et al. Multinational evidence-based recommendations for the diagnosis and management of gout: integrating systematic literature review and expert opinion of a broad panel of rheumatologists in the 3e initiative. Ann Rheum Dis. 2014;73:328–35.

    Article  PubMed  Google Scholar 

  37. Zhang W, Doherty M, Bardin T, et al. EULAR evidence based recommendations for gout. Part II: management. Report of a task force of the EULAR Standing Committee for International Clinical Studies including Therapeutics (ESCISIT). Ann Rheum Dis. 2006;65:1312–24.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Khanna PP, Gladue HS, Singh MK, et al. Treatment of acute gout: a systematic review. Semin Arthritis Rheum. 2014;44:31–8.

    Article  CAS  PubMed  Google Scholar 

  39. Wechalekar MD, Vinik O, Moi JH, et al. The efficacy and safety of treatments for acute gout: results from a series of systematic literature reviews including Cochrane reviews on intraarticular glucocorticoids, colchicine, nonsteroidal anti-inflammatory drugs, and interleukin-1 inhibitors. J Rheumatol. 2014;41 Suppl 92:15–25.

    Google Scholar 

  40. van Durme CM, Wechalekar MD, Buchbinder R, Schlesinger N, van der Heijde D, Landewe RB. Non-steroidal anti-inflammatory drugs for acute gout. Cochrane Database Syst Rev. 2014;9, CD010120.

    PubMed  Google Scholar 

  41. van Durme CM, Wechalekar MD, Landewe RB. Nonsteroidal anti-inflammatory drugs for treatment of acute gout. JAMA. 2015;313:2276–7.

    Article  PubMed  Google Scholar 

  42. Keenan RT, O’Brien WR, Lee KH, Crittenden DB, Fisher MC, Goldgarb DS, Krasnokutsky S, Oh C, Pillinger MH. Prevalence of contraindications and prescription of pharmacologic therapies for gout. Am J Med. 2011;124:155–63.

    Article  PubMed  Google Scholar 

  43. Saag KG, Olivieri JJ, Patino F, Mikuls TR, Allison JJ, MacLean CH. Measuring quality in arthritis care: the Arthritis Foundations’s quality indicator set for analgesics. Arthritis Rheum. 2004;51:337–49.

    Article  PubMed  Google Scholar 

  44. Risser A, Donovan D, Heintzman J, Page T. NSAID prescribing precautions. Am Fam Phys. 2009;80:1371–8.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Departments of Medicine and Epidemiology and Public Health, University of Maryland School of Medicine, 10 S. Pine St., MSTF 8-34, Baltimore, MD, 21201, USA

    Marc C. Hochberg M.D., M.P.H., M.A.C.P., M.A.C.R.

  2. SDG, LLC, Cambridge, MA, USA

    Lee S. Simon M.D., F.A.C.P., F.A.C.R.

Authors
  1. Marc C. Hochberg M.D., M.P.H., M.A.C.P., M.A.C.R.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lee S. Simon M.D., F.A.C.P., F.A.C.R.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Marc C. Hochberg M.D., M.P.H., M.A.C.P., M.A.C.R. .

Editor information

Editors and Affiliations

  1. IIS Aragón, CIBER Enfermedades Hepáicas y Digestivas (CIBERehd), Universidad de Zaragoza, Zaragoza, Spain

    Angel Lanas

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Hochberg, M.C., Simon, L.S. (2016). Efficacy of NSAIDs in the Treatment of Rheumatic Diseases. In: Lanas, A. (eds) NSAIDs and Aspirin. Springer, Cham. https://doi.org/10.1007/978-3-319-33889-7_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-33889-7_3

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-33887-3

  • Online ISBN: 978-3-319-33889-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation